4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001724310-26-000004
President and CEO sold 35,198 shares at $16.50 ($580,767)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-06 | Sale : show line 1 in the form | −35,198 | $16.50 | $580,767 | 296,833 | D |
| Open-market sales · 35,198 sh · avg $16.50 · $580,767 | ||||||
Loading xslF345X05/wk-form4_1767907202.xml…